Question 1

What is the catalog number for N- (4- (4- ((3- (Trifluoromethyl) phenyl) amino) -3,5-thiazolyl) phenyl) ethanamide?

Accepted Answer

The catalog number for N- (4- (4- ((3- (Trifluoromethyl) phenyl) amino) -3,5-thiazolyl) phenyl) ethanamide is FT169693.

Question 2

What sizes are available for N- (4- (4- ((3- (Trifluoromethyl) phenyl) amino) -3,5-thiazolyl) phenyl) ethanamide?

Accepted Answer

N- (4- (4- ((3- (Trifluoromethyl) phenyl) amino) -3,5-thiazolyl) phenyl) ethanamide is available in the following size(s): 5000 mg.

Question 3

Is N- (4- (4- ((3- (Trifluoromethyl) phenyl) amino) -3,5-thiazolyl) phenyl) ethanamide in stock?

Accepted Answer

N- (4- (4- ((3- (Trifluoromethyl) phenyl) amino) -3,5-thiazolyl) phenyl) ethanamide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 5

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 6

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

N- (4- (4- ((3- (Trifluoromethyl) phenyl) amino) -3,5-thiazolyl) phenyl) ethanamide

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Frequently Asked Questions

Explore Other Products

EGFR (Epidermal Growth Factor Receptor) (GFR/2341), CF640R conjugate, 0.1mg/mL

IL3RA / CD123 (Acute Myeloid Leukemia Marker) (IL3RA/1531), CF568 conjugate, 0.1mg/mL

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), 0.2mg/mL

Anti-SSH1 Antibody Picoband®

EGFRvIII (Epidermal Growth Factor Receptor, Variant III) (GFR/2600R), CF568 conjugate, 0.1mg/mL

Cytokeratin, LMW (AE-1), Biotin conjugate, 0.1mg/mL